Akèy › Dislipidemi
Etid klinik pou Dislipidemi ap rekrite nan Etazini
16 etid pou Dislipidemi ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Sep 18, 2026 · NCT07491172Intermittent Cottonseed Oil Consumption
Ap rekriteVolontè an sante akeyi
Laj 25 a 75 · Tout sèks · Mizajou Sep 9, 2026 · NCT07246408Cottonseed Oil Versus Matched PUFA Effects
Ap rekriteVolontè an sante akeyi
Laj 25 a 75 · Tout sèks · Mizajou Sep 9, 2026 · NCT06382298A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Aug 24, 2026 · NCT06980428A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
Ap rekrite
Laj 18 a 64 · Tout sèks · Mizajou Aug 12, 2026 · NCT07238556Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Ap rekriteFaz 3
Laj 2 a 11 · Tout sèks · Mizajou Jul 24, 2026 · NCT06597006Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT06300450Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Ap rekriteFaz 3
Laj 6 a 11 · Tout sèks · Mizajou May 15, 2026 · NCT06597019Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Apr 9, 2026 · NCT06496243Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions
Ap rekriteEtid obsèvasyon
Laj 10 a 90 · Tout sèks · Mizajou Mar 23, 2026 · NCT06676046PILI 'Āina Household
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 4, 2026 · NCT06526273'Ai Pono Cooking Demonstrations
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Mar 4, 2026 · NCT06526650Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Dec 17, 2025 · NCT05488431Gut Microbiota in Metabolic Surgery
Ap rekriteEtid obsèvasyon
Laj 21 a 65 · Tout sèks · Mizajou Nov 4, 2025 · NCT05000996Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
Ap rekriteVolontè an sante akeyi
Laj 20 ak plis · Tout sèks · Mizajou Oct 27, 2025 · NCT07221279Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2025 · NCT05129345Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.